Anastrozole Tablet
Product Images NDC 68071-5203

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 68071-5203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5203 3)

FDA Label Image

Figure 1 (Anastrozole Fig1)

FDA Label Image

Figure 2 (Anastrozole Fig2)

FDA Label Image

Figure 3 (Anastrozole Fig3)

FDA Label Image

Figure 4 (Anastrozole Fig4)

FDA Label Image

Figure 5 (Anastrozole Fig5)

Figure 5 (Anastrozole Fig5)
This text seems to be a report related to a medical condition. The report might be documenting the progress of a treatment involving two drugs - Anastrozole and Tamoxifen. The report includes a table showing some values over a period of time but without any clear headings or context. The text seems to be missing some important details and lacks overall coherence.*
FDA Label Image

Figure 6 (Anastrozole Fig6)

FDA Label Image

Chemical Structure For Anastrozole (Anastrozole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.